FIDELITY COVINGTON TRUST - MSCI HLTH CARE I (FHLC)

CUSIP: 316092600

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / MSCI HLTH CARE I
Total 13F shares
3,257,369
Share change
-383,830
Total reported value
$112,129,792
Price per share
$34.45
Number of holders
62
Value change
-$12,797,463
Number of buys
44
Number of sells
19

Security key

316092600

Report period

Q3 2016

Institutions

62

Top holders

10

Ownership snapshot

Top shareholders of FHLC - FIDELITY COVINGTON TRUST - MSCI HLTH CARE I (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
3,257,369
Rows loaded
62
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
58
Q3 2016 holders
62
Holder diff
4
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 value Q3 2016 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .